MAPT and Atrophy: Regarding biomarkers, patients with LATE-like patterns had a significantly higher IMT ratio, amygdalar atrophy, and lower tau SUVR in the global ROI and all Braak stages, except for I-II, than AD-like subjects (p < 0.001) (Table 2).